These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7998478)

  • 1. Prostacyclin and nitric oxide.
    Gryglewski RJ
    Acta Haematol Pol; 1994; 25(2 Suppl 2):75-81. PubMed ID: 7998478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vascular endothelium in the processes of hemostasis and thrombosis. The role of prostacyclin and EDRF].
    Radomski MW
    Acta Physiol Pol; 1989; 40 Suppl 33():97-109. PubMed ID: 2489269
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure.
    Miyaji K; Nagata N; Miyamoto T; Kitahori K
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):437-9. PubMed ID: 12579126
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitric oxide and the cardiovascular system.
    Welch G; Loscalzo J
    J Card Surg; 1994 May; 9(3):361-71. PubMed ID: 8054733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of exercise: role of endothelial shear stress.
    Niebauer J; Cooke JP
    J Am Coll Cardiol; 1996 Dec; 28(7):1652-60. PubMed ID: 8962548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of the endothelium.
    Lüscher TF; Barton M
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-3-10. PubMed ID: 9422846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitric oxide: an intercellular gas with physiological and toxic actions. New perspectives].
    de Berrazueta JR
    Rev Esp Cardiol; 1994 Apr; 47(4):199-208. PubMed ID: 8209086
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivo.
    Sinzinger H; Fitscha P; Rauscha F; O'Grady J; Rogatti W; Vane JR
    Prog Clin Biol Res; 1990; 355():55-62. PubMed ID: 2177897
    [No Abstract]   [Full Text] [Related]  

  • 10. Oh no, not nitric oxide!
    Bhagat K
    Cent Afr J Med; 1999 Jun; 45(6):160-3. PubMed ID: 10695189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
    Warner TD
    Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation.
    Vane JR
    Philos Trans R Soc Lond B Biol Sci; 1994 Jan; 343(1304):225-46. PubMed ID: 8146236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide, prostacyclin (PGI2) and tissue plasminogen activator (t-PA): alliance or neutrality?
    Gryglewski RJ
    Pol J Pharmacol; 1995; 47(5):467-72. PubMed ID: 8868142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
    Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS
    Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
    Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
    Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.
    Golzand E; Bar-Oz B; Arad I
    Isr Med Assoc J; 2005 Jun; 7(6):408-9. PubMed ID: 15984391
    [No Abstract]   [Full Text] [Related]  

  • 18. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
    Badalian SS; Silverman RK; Aubry RH; Longo J
    J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO in the cardiovascular system.
    Shah AM; Vallance P; Harrison D
    Cardiovasc Res; 1999 Aug; 43(3):507-8. PubMed ID: 10690322
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between prostacyclin and nitric oxide in the thrombotic process.
    Moncada S; Palmer RM; Higgs EA
    Thromb Res Suppl; 1990; 11():3-13. PubMed ID: 2278041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.